最后更新: 2026年5月18日

Renal cancer is often a silent malignancy, but the increasing use of ultrasound and CT scan during routine health checkups has led to the incidental detection of Small Renal Masses (SRMs). SRMs are defined as solid kidney lesions smaller than 4 cm. Approximately 80% of SRMs turn out to be cancer and 20% are benign. Traditionally, urologists recommended surgery for all SRMs, but this sometimes resulted in unnecessary operations when the pathology came back benign — which is why renal mass biopsy has become increasingly utilized.

Renal cancer biopsy surgery
Traditionally, urologists encouraged everyone with SRMs to undergo surgery.

Renal cancer biopsy was developed to prevent over-treatment of benign and low-grade tumors, and to guide the most suitable treatment modality for each individual. The biopsy is an outpatient procedure performed with the patient in a prone position. Local anesthesia is injected at the flank area over the targeted kidney, and tissue cores are sampled under ultrasound or CT guidance.

Renal mass biopsy outpatient
Renal mass biopsy can be done on an outpatient basis.

Technical considerations for renal cancer biopsy

  1. Obesity – skin-to-mass distance may affect needle access
  2. Position of the renal mass – posterior masses are easier to access than anterior masses
  3. Number of biopsy cores – 2 to 3 cores are recommended for adequate sampling
  4. Accuracy rate – up to 92% reported in the literature

Safety profile of renal cancer biopsy

  1. Less than 2% complication rate – including perinephric hematoma, flank pain, hematuria, and pneumothorax
  2. Massive bleeding is rare and almost always self-limited
  3. Tumor seeding along the biopsy tract is nearly negligible with modern coaxial biopsy technique

Once pathology is available, the following management plan applies:

  1. Renal cancer confirmed – treatment modality (surgery, ablation, or active surveillance) is tailored to each patient
  2. Benign mass confirmed – regular imaging surveillance recommended; repeat biopsy is reconsidered if:
    • Tumor grows beyond 4 cm in maximum diameter
    • Growth rate exceeds 5 mm per year
Shared decision making renal mass
Small renal mass management requires shared decision-making and a good doctor-patient relationship.

Small renal mass management is a sensitive issue that requires shared decision-making and a strong doctor-patient relationship. Patients can understandably feel anxious about a possible kidney cancer without a clear treatment plan. Our approach is always to provide transparent, evidence-based guidance tailored to each individual.

你可以访问我的官方主页 这里.

Frequently Asked Questions About Renal Cancer Biopsy

What is a small renal mass (SRM) and does it need to be biopsied?

A small renal mass (SRM) is a solid kidney lesion less than 4 cm in size, typically detected incidentally on ultrasound or CT scan during a health checkup. Approximately 80% of SRMs are malignant and 20% are benign. Renal mass biopsy is recommended when the result will change the treatment plan — for example, to confirm malignancy before surgery, to guide ablation therapy, or to avoid unnecessary surgery in patients who are not surgical candidates. The procedure achieves up to 92% diagnostic accuracy.

Is renal mass biopsy safe?

Yes. Renal mass biopsy has a very low complication rate of less than 2%, with reported complications including perinephric hematoma, flank pain, hematuria, and pneumothorax. Massive bleeding is rare and almost always self-limited. Tumor seeding along the biopsy tract is nearly negligible with modern coaxial technique. The procedure is performed as an outpatient under local anesthesia with ultrasound or CT guidance.

What happens after renal mass biopsy results?

If the biopsy confirms renal cancer, treatment is tailored to the individual — options include surgical resection (partial or radical nephrectomy), ablation therapy, or active surveillance for low-risk tumors. If the biopsy confirms a benign mass, regular imaging surveillance is recommended. Repeat biopsy is reconsidered if the mass grows beyond 4 cm or at a rate exceeding 5 mm per year. All decisions are made collaboratively with the patient based on the latest evidence-based guidelines.

If you have been found to have a renal mass and would like a specialist evaluation, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. 预约咨询.

**免责声明:** 本内容由曼谷医院总院的认证泌尿科医生 Soarawee Weerasopone 医生撰写和审阅。本内容仅用于教育目的,不构成医疗建议。在开始任何医疗治疗前,请务必咨询合格的医疗专业人士。.

医学撰写与审阅: 素瓦瑞·维拉宋蓬医生(Pom医生)— 曼谷医院总部认证泌尿科医生。 国际学者:贝勒医学院(美国)· 顺天堂大学(日本)· 长庚纪念医院(台湾)。.

zh_CN简体中文

了解 Dr. Soarawee Weerasopone — Urologist Bangkok 的更多信息

立即订阅以继续阅读并访问完整档案。

继续阅读